Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Hold
3,435
0.05% 62
2026
Q1
$833K Sell
3,435
-175
-5% -$47.4K 0.05% 61
2025
Q4
$1.07M Hold
3,610
0.06% 63
2025
Q3
$1.02M Sell
3,610
-257
-7% -$67.3K 0.06% 64
2025
Q2
$1.14M Sell
3,867
-556
-13% -$143K 0.08% 57
2025
Q1
$1.1M Buy
4,423
+2,548
+136% +$623K 0.08% 54
2024
Q4
$412K Hold
1,875
0.03% 80
2024
Q3
$415K Buy
1,875
+296
+19% +$58K 0.03% 75
2024
Q2
$273K Hold
1,579
0.02% 81
2024
Q1
$302K Hold
1,579
0.02% 80
2023
Q4
$258K Buy
+1,579
New +$239K 0.02% 81
2023
Q1
Sell
-579
Closed -$81.6K 96
2022
Q4
$81.6K Buy
+579
New +$79.9K 0.01% 96

Other funds holding IBM

Rebalance's IBM Position: Q2 2026 in Review

Rebalance held its IBM (IBM) position steady in Q2 2026 at 3,435 shares worth $966K. The position accounts for 0.05% of the portfolio, ranked #62.

Rebalance first reported a position in IBM in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.14M in Q2 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Rebalance held 3,435 shares of IBM worth $966K as of Q2 2026.
  • Rebalance left its IBM share count unchanged in Q2 2026.
  • IBM made up 0.05% of Rebalance's portfolio in Q2 2026, its #62 holding.
  • Rebalance first reported a position in IBM in Q4 2022 and has held it in 12 quarters since.
  • Rebalance's IBM position peaked at $1.14M in Q2 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.